Allspring Global Investments Holdings LLC grew its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 1.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 705,400 shares of the health services provider's stock after acquiring an additional 8,667 shares during the period. Allspring Global Investments Holdings LLC owned 1.16% of Maximus worth $65,715,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in MMS. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock worth $27,707,000 after buying an additional 292,300 shares during the last quarter. Millennium Management LLC increased its stake in shares of Maximus by 150.4% during the second quarter. Millennium Management LLC now owns 406,075 shares of the health services provider's stock worth $34,801,000 after purchasing an additional 243,890 shares during the period. Vanguard Group Inc. boosted its stake in shares of Maximus by 2.4% in the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider's stock valued at $520,922,000 after buying an additional 145,983 shares during the period. Algert Global LLC bought a new stake in shares of Maximus during the 2nd quarter worth approximately $12,424,000. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Maximus by 151.6% in the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider's stock worth $19,980,000 after acquiring an additional 140,481 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider Michelle F. Link sold 1,363 shares of the business's stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.40% of the stock is owned by insiders.
Maximus Trading Down 1.1 %
NYSE MMS traded down $0.99 on Tuesday, reaching $87.09. The company had a trading volume of 268,659 shares, compared to its average volume of 347,007. The firm has a market cap of $5.29 billion, a price-to-earnings ratio of 22.87 and a beta of 0.76. The business has a 50 day moving average of $90.09 and a two-hundred day moving average of $87.31. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59. Maximus, Inc. has a fifty-two week low of $72.81 and a fifty-two week high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, topping analysts' consensus estimates of $1.47 by $0.27. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company posted $0.78 earnings per share. Maximus's quarterly revenue was up 10.6% compared to the same quarter last year. Analysts forecast that Maximus, Inc. will post 6.12 EPS for the current year.
Maximus Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.38%. Maximus's payout ratio is 31.50%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
